Skip to main navigation Skip to search Skip to main content

THE ROLE OF SOLUBLE PROGRAMMED CELL DEATH PROTEIN 1 ON HBV RELAPSE AND HBsAg LOSS AFTER CESSATION OF ENTECAVIR THERAPY IN HBEAG-POSITIVE AND HBEAG-NEGATIVE NON-CIRRHOTIC PATIENTS

  • Chien Hung Chen
  • , Jing-Houng Wang
  • , Tsung-Hui Hu
  • , Chao-Hung Hung
  • , Sheng-Nan Lu

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalHepatology
Volume70
StatePublished - 2019

Cite this